PMID: 9191482Oct 1, 1996Paper

A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction

The Canadian Journal of Cardiology
P Vantrimpont, J L Rouleau

Abstract

Which patients with an acute myocardial infarction should be treated with an angiotensin-converting enzyme (ACE) inhibitor and when should this treatment be initiated? Combining pathophysiological evidence with the findings of large clinical trials, it is recommended that in the postinfarction setting ACE inhibitors should be given only to high risk patients, ie, patients with arterial hypertension, patients in Killip class II or III, patients with an acute anterior myocardial infarction, patients with left ventricular dysfunction and patients with a previous myocardial infarction. Treatment should be started as soon as it is considered safe.

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.